Related Experiment Video
Updated: Aug 5, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
The False Claims Act and clinical laboratories
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association
|August 6, 1993
Summary
The False Claims Act combats federal fraud with triple damages and penalties. Its qui tam provision empowers whistleblowers to report fraud, protecting government funds.
Area of Science:
- Law and Government
- Healthcare Compliance
- Fraud Detection
Background:
- The U.S. government increasingly utilizes the civil False Claims Act to combat fraud.
- This act enforces severe penalties, including triple damages, for defrauding federal entities.
- Whistleblowers are incentivized with substantial bounties to report fraudulent activities.
Purpose of the Study:
- To provide a comprehensive overview of the False Claims Act.
- To detail the qui tam provision concerning whistleblowers.
- To examine the Act's specific application within clinical laboratories.
Main Methods:
- Review of the False Claims Act legislation.
- Analysis of the qui tam provision's mechanisms.
- Case study examination of False Claims Act applications in clinical laboratory settings.
Main Results:
- The False Claims Act serves as a critical tool for fraud recovery.
- The qui tam provision effectively encourages whistleblower participation.
- Clinical laboratories face significant legal and financial risks under the Act.
Conclusions:
- The False Claims Act is a powerful deterrent against federal fraud.
- Whistleblower protections and incentives are crucial for enforcement.
- Understanding the Act's implications is vital for clinical laboratory compliance.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:19MALDI-TOF Mass Spectrometry
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...